Société Générale — M&A Activity 2021

Jul 1, 2021

National Storage Mechanism | Additional information

RNS Number : 8018D

Societe Generale SA

01 July 2021

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1.       KEY INFORMATION

Name of person dealing (Note 1)	Société Générale S.A.
Company dealt in	UDG Healthcare plc
Class of relevant security to which the dealings being disclosed relate (Note 2)	€0.05 ordinary shares
Date of dealing	30/06/2021

2.         INTERESTS AND SHORT POSITIONS

(a)        Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

	Long		Short
Number	(%)	Number	(%)
(1) Relevant securities	16,821,398	6.68	12,058	0.00
(2) Derivatives (other than options)	0	0.00	10,621,455	4.22
(3) Options and agreements to purchase/sell	0	0.00	0	0.00
Total	16,821,398	6.68	10,633,513	4.22

(b)        Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:	Long		Short
	Number	(%)	Number	(%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total

Ap20

1.       DEALINGS (Note 4)

(a)      Purchases and sales

Purchase/sale	Number of relevant securities	Price per unit GBP (Note 5)
Purchase	390	10.71
Purchase	15,000	10.69
Purchase	837,977	10.7
Sale	43	10.71
Sale	37	10.71
Sale	25	10.71
Sale	505	10.71
Sale	199	10.71
Sale	8	10.71
Sale	93	10.71
Sale	53	10.71
Sale	44	10.71
Sale	14	10.71
Sale	59	10.71
Sale	28	10.71
Sale	218	10.71
Sale	256	10.71
Sale	42	10.71
Sale	49	10.71
Sale	366	10.69
Sale	1,465	10.69
Sale	423	10.69
Sale	366	10.69
Sale	366	10.69
Sale	366	10.69
Sale	366	10.69
Sale	1,465	10.69
Sale	1,465	10.69
Sale	1,465	10.69
Sale	73	10.69
Sale	1,465	10.69
Sale	291	10.69
Sale	210	10.7
Sale	679	10.7
Sale	246	10.7
Sale	117	10.7
Sale	235	10.7
Sale	338	10.7
Sale	133	10.7
Sale	208	10.7
Sale	250	10.7
Sale	4,376	10.7
Sale	250	10.7
Sale	467	10.7
Sale	120	10.7
Sale	200	10.7
Sale	342	10.7
Sale	216	10.7
Sale	617	10.71
Sale	1,280	10.71
Sale	258	10.69
Sale	8	10.7
Sale	197	10.7
Sale	13	10.7
Sale	311	10.7
Sale	6	10.7
Sale	13	10.7
Sale	77	10.7
Sale	20	10.7
Sale	123	10.7
Sale	70	10.7
Sale	147	10.7
Sale	13	10.7
Sale	224	10.7
Sale	49	10.7
Sale	179	10.7
Sale	22	10.7
Sale	68	10.7
Sale	203	10.7
Sale	203	10.7
Sale	225	10.69
Sale	201	10.7
Sale	281	10.7
Sale	356	10.69
Sale	275	10.7
Sale	580	10.69
Sale	1,095	10.69
Total Purchases	853,367
Total Sales	27,116

Derivatives transactions (other than options transactions)

Product name, e.g. CFD	Nature of transaction (Note 6)	Number of relevant securities (Note 7)	Price per unit GBP (Note 5)
CFD	Increased short	15,000	10.69

(b)      Options transactions in respect of existing relevant securities

(i)       Writing, selling, purchasing or varying

Product name, e.g. call option	Writing, selling, purchasing, varying etc.	Number of securities to which the option relates (Note 7)	Exercise price	Type, e.g. American, European etc.	Expiry date	Option money paid/received per unit (Note 5)

(ii)      Exercising

Product name, e.g. call option	Number of securities	Exercise price per unit (Note 5)

(c)      Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction (Note 8)	Details	Price per unit (if applicable) (Note 5)

Ap21

2.       OTHER INFORMATION

Agreements, arrangements, or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any

relevant securities to which any derivative referred to on this form is referenced. If none, this

should be stated.

Is a Supplemental Form 8 attached? (Note 9)                                            No

Date of disclosure	01/07/2021
Contact name	Société Générale - Disclosure team
Telephone number	+33 1 42 14 92 74
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection (Note 10)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ISEUPUMPMUPGUAG